Commandité
Advances in VEGF Inhibitors for Cancer and Eye Disease
Introduction to VEGF Inhibitors Vascular endothelial growth factor (VEGF) is essential for angiogenesis, the process of forming new blood vessels. While critical for normal physiological functions like wound healing, abnormal VEGF activity contributes to diseases such as cancer, diabetic retinopathy, and age-related macular degeneration. The development of VEGF Inhibitors Market therapies has...
0 Commentaires 0 Parts 609 Vue 0 Aperçu
Commandité
Commandité
Commandité